載入...
Oncolytic virotherapy using herpes simplex virus: how far have we come?
Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. The human pathogen herpes simplex virus (HSV) has proven particularly amenable for use in oncolytic virotherapy. The relative safety of HSV coupled with extensive knowledge on how HSV interacts wit...
Na minha lista:
| 發表在: | Oncolytic Virother |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918397/ https://ncbi.nlm.nih.gov/pubmed/27512683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66086 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|